JPMorgan raised the firm’s price target on Allstate to $162 from $150 and keeps an Overweight rating on the shares. The analyst maintains a positive stance on the property and casualty sector in the Q2 reports. The firm projects results will benefit from “firm” prices and higher interest rates and it expects the group to be “defensive in a downturn.” On the other hand, earnings forecasts for P&C insurers “seem optimistic” and the stocks have outperformed other financials, the analyst tells investors in a research note. While JPMorgan’s outlook on the group remains upbeat, it is “less so than previously.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALL:
- Allstate price target lowered to $137 from $141 at Piper Sandler
- ‘Load Up,’ Says Raymond James About These 2 ‘Strong Buy’ Stocks
- Allstate vs. MetLife: Which Insurance Stock is Better?
- IBM (NYSE:IBM) Preparing to Buy Apptio; Adding to Pile of Collaborations
- Philip Morris upgraded, Palantir downgraded: Wall Street’s top analyst calls